Enzon Pharmaceuticals Inc (ENZN.OQ)

ENZN.OQ on NASDAQ Stock Exchange Capital Market

1.71USD
29 Aug 2014
Price Change (% chg)

$0.14 (+9.29%)
Prev Close
$1.28
Open
$1.60
Day's High
$1.60
Day's Low
$1.60
Volume
73,380
Avg. Vol
130,325
52-wk High
$1.74
52-wk Low
$0.78

ENZN.OQ

Chart for ENZN.OQ

About

Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company’s drug development programs utilize two platforms: Customized PEGylation Linker Technology (Customized Linker Technology) and third-generation messenger ribonucleic acid (mRNA) antagonists utilizing the Locked Nucleic Acid (LNA) technology. The Company... (more)
No analyst recommendations are available for ENZN.OQ.

Overall

Beta: 1.31
Market Cap (Mil.): $72.37
Shares Outstanding (Mil.): 44.13
Dividend: 0.45
Yield (%): --

Financials

  ENZN.OQ Industry Sector
P/E (TTM): 2.76 153.62 33.23
EPS (TTM): 0.59 -- --
ROI: 150.45 -3.27 17.21
ROE: 152.47 -7.88 18.01
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks